Norstella LinQ establishes a throughline between the company’s various subsidiaries, utilizing capabilities from Citeline, ...

Aviadobio Ltd. has entered a potential $2.18 billion license and commercialization agreement for its frontotemporal dementia gene therapy, AVB-101, with Astellas Pharma Inc. Astellas is making a $20 ...

Shares of newly IPO’ed peptide therapy developer MBX Biosciences (NASDAQ:MBX) traded sharply lower on Tuesday, even as several Wall Street firms launched its coverage with buy recommendations.

Dishant Gupta, a former pharma executive from N.J., pled guilty to insider trading and could face up to 20 years in prison.

Is your company bracing for Milton or working to provide aid in anticipation of the storm? | Pfizer—which opened a global hub ...

For the pharma industry, the report highlights ways in which it can be a partner in healthcare innovation and support the NHS.

Programmed Cell Death Protein-1 (PD-1) represents endogenous mechanisms of negative immunoregulation. While the modulation of effector functions has been the major focus of PD-1 research, quick PD-1 ...

Mitem Pharma acquired from Novartis worldwide rights to Desferal, commonly used to lower excessive iron levels induced by ...

Royalty Pharma (RPRX) could be a solid addition to your portfolio given its recent upgrade to a Zacks Rank #2 (Buy). An upward trend in earnings estimates -- one of the most powerful forces impacting ...

Ascendis Pharma ASND has outperformed the market over the past 10 years by 39.55% on an annualized basis producing an average ...

Eversana is increasing its reach across the global pharmaceutical industry. | Eversana is increasing its reach across the ...

Mr. Shkreli was convicted of defrauding investors and sentenced in 2018 to seven years in prison; he served about five years. A federal judge also banned Mr. Shkreli from the pharmaceutical industry ...